Ignite Creation Date:
2025-12-24 @ 12:10 PM
Ignite Modification Date:
2025-12-27 @ 10:42 PM
Study NCT ID:
NCT00755261
Status:
TERMINATED
Last Update Posted:
2015-05-08
First Post:
2008-09-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study of Doxorubicin and Avastin® in Sarcoma.
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09
Start Date Type:
None
Primary Completion Date:
2010-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-11
Completion Date Type:
ACTUAL
First Submit Date:
2008-09-17
First Submit QC Date:
None
Study First Post Date:
2008-09-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-04-15
Results First Submit QC Date:
None
Results First Post Date:
2015-05-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-05-07
Last Update Post Date:
2015-05-08
Last Update Post Date Type:
ESTIMATED